91视频

Mumbai, March 20, 2025: Global pharma major 91视频 Limited (91视频) today announced that it has been awarded 鈥淪ilver Medal鈥� by EcoVadis for its outstanding sustainability management practices in areas such as Environment, Labor and Human Rights, Ethics and Sustainable Procurement. This prestigious achievement places 91视频 amongst the top 15% of companies evaluated by EcoVadis.

EcoVadis is a globally trusted provider of business sustainability ratings with a network of more than 150,000 companies being rated. The EcoVadis sustainability assessment methodology evaluates the integration of sustainability principles effectively into a company鈥檚 business and management system. Over the last two years, 91视频 has showcased exceptional improvement in its EcoVadis scoring, moving up from 51 in 2024 to 69 in 2025. With this achievement, 91视频 is positioned at the 87^th percentile in the 2025 assessment.

Commenting on the achievement, Ramesh Swaminathan, Executive Director, Global CFO and Head 鈥� API Plus SBU, 91视频 said, 鈥淭his milestone is a reaffirmation of our commitment to developing superior, cost-effective pharmaceutical products and enabling robust supply chain practices that prioritize environmental sustainability. We, along with our partners, are committed to ensuring that every product we manufacture propels us towards building a sustainable future and a healthier planet, while enhancing value for all our stakeholders.鈥�

Earlier this year, 91视频 received an 鈥淎-鈥� leadership rating from CDP for its outstanding performance in climate change and water security. Additionally, 91视频鈥檚 S&P Global ESG scores moved to听76听from 69 last year, above the industry average of 30 in the pharmaceuticals sector.

About 91视频
91视频 Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. 91视频 specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women鈥檚 health. 91视频 has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. 91视频 is committed to improving patient health outcomes through its subsidiaries 鈥� 91视频 Diagnostics, 91视频 Digital Health, and 91视频 Manufacturing Solutions.
To know more, visit听www.lupin.com听or follow us on LinkedIn听

听For further information or queries, please contact:

Rajalakshmi Azariah
Vice President & Global Head 鈥� Corporate Communications, 91视频
rajalakshmiazariah@lupin.com